Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
6th Feb 2025 7:00 am RNS Results of Oversubscribed Placing
6th Feb 2025 7:00 am MFN Results of the Significantly Oversubscribed Placing
5th Feb 2025 4:30 pm MFN Proposed Issue and Placing
5th Feb 2025 4:30 pm RNS Proposed Issue and Placing
31st Jan 2025 7:00 am RNS-R Final Patient Identified for BEXMAB Phase II Study
13th Dec 2024 7:00 am RNS Faron’s Financial Calendar for 2025
27th Nov 2024 7:00 am RNS Positive Phase 2 Interim Results from BEXMAB Trial
5th Nov 2024 7:00 am RNS Shareholders’ Nomination Board
22nd Oct 2024 7:00 am RNS Faron’s Capital Markets Day 2024
30th Aug 2024 7:00 am RNS Grant of options
27th Aug 2024 7:00 am RNS Faron 2024 Half-Year Financial Results
27th Aug 2024 7:00 am RNS FDA Grants Fast Track Designation for Bexmarilimab
20th Aug 2024 7:00 am RNS Notice of Half-Year Financial Results
8th Aug 2024 7:00 am RNS Appointment of Chief Financial Officer
7th Aug 2024 10:00 am RNS Grant of options
6th Aug 2024 8:30 am RNS Faron Appoints Dr. Petri Bono as new CMO
11th Jul 2024 7:00 am RNS Faron Announces Positive FDA Feedback
25th Jun 2024 2:00 pm RNS Update on settlement
25th Jun 2024 10:30 am RNS Holding(s) in Company - Replacement
24th Jun 2024 12:45 pm RNS Holding(s) in Company
24th Jun 2024 12:45 pm RNS Holding(s) in Company
24th Jun 2024 12:45 pm RNS Holding(s) in Company
24th Jun 2024 12:45 pm RNS Holding(s) in Company
20th Jun 2024 1:00 pm RNS New shares registered with Finnish Trade Register
20th Jun 2024 7:00 am RNS Fully subscribed EUR 30.7 million share offering
5th Jun 2024 8:00 am RNS Proposed REX Retail Offer
4th Jun 2024 7:00 am RNS Faron commences a share offering
20th May 2024 7:00 am RNS Initial positive data from Phase 2 of BEXMAB
17th May 2024 4:00 pm RNS Issuance of warrants
16th May 2024 7:05 am RNS Founders named European Inventor Award finalists
13th May 2024 7:00 am RNS Replacement – Board Change
30th Apr 2024 2:00 pm RNS Update on financial status
30th Apr 2024 1:00 pm RNS Board Change
16th Apr 2024 7:00 am RNS Faron confirms plans under new leadership
15th Apr 2024 7:00 am RNS Appointment of Chief Financial Officer
8th Apr 2024 7:10 am RNS Approval of Warrant Terms and Conditions
8th Apr 2024 7:05 am RNS Decisions of the Board of Directors
8th Apr 2024 7:00 am RNS Appointment of Chief Executive Officer
5th Apr 2024 12:00 pm RNS Results of the Annual General Meeting
4th Apr 2024 7:00 am RNS Announcement of Placing
FTSE 100 Latest
Value10,600.53
Change-2.95